New Key Statistics Module, Z-Score and F-Score
SZSE:002900 Key Ratios
Market Cap ¥ M | 2,717.79 |
Enterprise Value ¥ M | 2,499.54 |
P/E(ttm) | 50.53 |
PE Ratio without NRI | 60.92 |
Forward PE Ratio | -- |
Price/Book | 1.26 |
Price/Sales | 2.44 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.71 |
Revenue (TTM) ¥ M | 1,091.00 |
EPS (TTM) ¥ | 0.17 |
Beneish M-Score | -2.65 |
10-y EBITDA Growth Rate % | -2.40 |
5-y EBITDA Growth Rate % | -5.90 |
y-y EBITDA Growth Rate % | -27.20 |
EV-to-EBIT | 30.73 |
EV-to-EBITDA | 30.73 |
PEG | -- |
Shares Outstanding M | 316.39 |
Net Margin (%) | 4.88 |
Operating Margin % | -0.49 |
Pre-tax Margin (%) | 5.24 |
Quick Ratio | 1.16 |
Current Ratio | 1.36 |
ROA % (ttm) | 1.54 |
ROE % (ttm) | 2.52 |
ROIC % (ttm) | -0.19 |
Dividend Yield % | 2.32 |
Altman Z-Score | 1.91 |
SZSE:002900 Number of Guru Trades
SZSE:002900 Volume of Guru Trades
Gurus Latest Trades with SZSE:002900
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002900 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Harbin Medisan Pharmaceutical Co Ltd Insider Transactions
No Available Data